Dr. Cassandra Danielle Salgado, MD

Dr. Salgado practices at MUSC Physicians in Mount Pleasant, South Carolina.

Dr. Salgado's NPI, 1912015876, was assigned on August 29, 2006. Dr. Salgado graduated from West Virginia University School of Medicine in 1995. Dr. Salgado holds South Carolina license TL27310.

Dr. Salgado's primary practice is MUSC Physicians, at 1208 2 Island Ct, Mount Pleasant, SC 29466 in Charleston County. The practice phone is (803) 286-4666.

Dr. Salgado's primary practice is MUSC Physicians in Mount Pleasant, South Carolina. Dr. Salgado is also affiliated with MUSC Health University Medical Center. The medical group on file is MUSC Health. Dmand AI also links Dr. Salgado to 3 more medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Salgado practices, 3 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Salgado's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Salgado is licensed in South Carolina.

CMS data shows 193 Medicare services from Dr. Salgado across 3 procedure codes in 2024, for 110 Medicare patients. Medicare paid $14,550 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 110 Medicare patients who saw Dr. Salgado in 2024. The largest group is 65 to 74, with 39 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 3.29, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Salgado's median patient age at 59, with 44% women.

In 2024, Dr. Salgado wrote 58 Medicare Part D claims for 16 patients. 90% of them were for generic drugs. CMS names the drug for 18 of them, across 1 drug with 11 or more claims each, at $729 in total drug cost. In 2023, CMS named 75 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Salgado for performance year 2024, reported as part of a group. Dr. Salgado accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 40 papers to Dr. Salgado, published from 2006 to 2023. 2012 was the busiest year, with 5. The most frequent topics are Cross Infection, Infection Control and Staphylococcal Infections. Dr. Salgado has published most often in Infect Control Hosp Epidemiol. Dr. Salgado's most frequent co-authors are David P. Calfee, MD, Joseph R. Cantey, MD and Lisa L. Maragakis, MD.

CMS Open Payments shows 5 general payments to Dr. Salgado from 4 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $35.

Dr. Salgado graduated from West Virginia University School of Medicine in 1995.